Siemens Healthineers (OTCMKTS:SMMNY) Trading Down 1.5% – Here’s What Happened
by Mitch Edgeman · The Markets DailySiemens Healthineers AG (OTCMKTS:SMMNY – Get Free Report) dropped 1.5% during mid-day trading on Wednesday . The stock traded as low as $19.33 and last traded at $19.35. 116,609 shares were traded during mid-day trading, a decline of 31% from the average daily volume of 169,168 shares. The stock had previously closed at $19.65.
Analyst Ratings Changes
Separately, Zacks Research downgraded shares of Siemens Healthineers from a “hold” rating to a “strong sell” rating in a report on Friday, May 15th. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy”.
Read Our Latest Stock Analysis on SMMNY
Siemens Healthineers Stock Down 1.5%
The stock has a 50-day simple moving average of $20.35 and a 200 day simple moving average of $22.95.
Siemens Healthineers (OTCMKTS:SMMNY – Get Free Report) last released its quarterly earnings data on Thursday, May 7th. The company reported $0.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.29 by $0.02. The firm had revenue of $6.68 billion for the quarter, compared to the consensus estimate of $6.96 billion.
Siemens Healthineers Company Profile
Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.
The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.